HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of novel peptide inhibitors for human trypsins.

Abstract
Human trypsin isoenzymes share extensive sequence similarity, but certain differences in their activity and susceptibility to inhibitors have been observed. Using phage display technology, we identified seven different peptides that bind to and inhibit the activity of trypsin-3, a minor trypsin isoform expressed in pancreas and brain. All of the peptides contain at least two of the amino acids tryptophan, alanine and arginine, whereas proline was found closer to the N-terminus in all but one peptide. All peptides contain two or more cysteines, suggesting a cyclic structure. However, we were able to make synthetic linear variants of these peptides without losing bioactivity. Alanine replacement experiments for one of the peptides suggest that the IPXXWFR motif is important for activity. By molecular modeling the same amino acids were found to interact with trypsin-3. The peptides also inhibit trypsin-1, but only weakly, if at all, trypsin-2 and -C. As trypsin is a highly active enzyme which can activate protease-activated receptors and enzymes that participate in proteolytic cascades involved in tumor invasion and metastasis, these peptides might be useful lead molecules for the development of drugs for diseases associated with increased trypsin activity.
AuthorsPing Wu, Janne Weisell, Miikka Pakkala, Mikael Peräkylä, Lei Zhu, Riitta Koistinen, Erkki Koivunen, Ulf-Håkan Stenman, Ale Närvänen, Hannu Koistinen
JournalBiological chemistry (Biol Chem) 2010 Feb-Mar Vol. 391 Issue 2-3 Pg. 283-293 ISSN: 1437-4315 [Electronic] Germany
PMID20128688 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Recombinant Fusion Proteins
  • Trypsin Inhibitors
  • PRSS2 protein, human
  • Trypsinogen
  • PRSS1 protein, human
  • PRSS3 protein, human
  • Trypsin
Topics
  • Binding Sites (drug effects)
  • Dose-Response Relationship, Drug
  • Humans
  • Models, Molecular
  • Recombinant Fusion Proteins (chemistry, genetics, pharmacology)
  • Structure-Activity Relationship
  • Trypsin (metabolism)
  • Trypsin Inhibitors (chemistry, genetics, pharmacology)
  • Trypsinogen (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: